Stent FREDX4013-PMARecalls & reported problems
Microvention, Inc. · FRED-X 27 · Class 3 · Implant
All models of Stent (63)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 3
- Deaths reported
- 1
- Injuries reported
- 2
- Recalls naming it
- 1
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00842429114346), received between Jan 6, 2025 and Feb 3, 2026 — classified as 1 death, 2 injuries.
The most frequently reported specific device problem is “Activation Failure” (1 report).
1 FDA recall record name this device's identifier, 1 still open.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Recalls naming this device
- Sep 5, 2025Open, Classified
Flow diverter may have a manufacturing issue related to the tantalum length and/or tantalum attachment pattern, which may lead the device to be incompletely open or not properly apposed to the vessel wall, which may necessitate device recapture and withdrawal of the delivery system and microcatheter together. Insufficient apposition could lead to long-term health consequences.
Z-0108-2026 · Root cause: Device Design · Recall details · FDA record ↗
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
- Activation Failure1
- Difficult or Delayed Positioning1
- Unintended Movement1
Patient problems
- Obstruction/Occlusion2
- Muscle Weakness/Atrophy1
- Numbness1
- Stenosis1
- Thrombosis/Thrombus1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjuryFeb 3, 2026Adverse Event Without Identified Device or Use Problem
ADDITIONAL INFORMATION RECEIVED PROVIDED THE DEVICE MODEL & LOT NUMBER AND INDICATED: ORIGINAL SURGICAL DATE / STUDY PROCEDURE WAS ON (B)(6) 2024. CORELAB REPORTED THE 40% IN-STENT STENOSIS AT THE 6-MONTH FU IMAGING AND THE CLINICAL SITE REPORTED 90% TARGET ANEURYSM OCCLUSION AT THE 6-MONTH FU IMAGING ALL PERFORMED ON (B)(6) 2024. THE CLINICAL SITE REPORTED 20% TARGET ANEURYSM OCCLUSION AT THE 1-YR FU IMAGING PERFORMED ON (B)(6) 2025. RECANALIZATION HAS NOT BEEN CONFIRMED. NO TREATMENT WAS REQUIRED FOR THE 40% IN-STENT STENOSIS. NO TREATMENT WAS ADMINISTERED FOR AE IN-STENT STENOSIS/INTIMAL HYPERPLASIA OR VITREOUS FLOATERS OF BOTH EYES. TO DATE, NO FURTHER INFORMATION HAS BEEN PROVIDED.
Patient problems: Obstruction/Occlusion; Stenosis
MAUDE report 24254521 ↗DeathOct 15, 2025Difficult or Delayed Positioning; Unintended Movement; Activation Failure; Difficult or Delayed Positioning; Unintended Movement; Activation Failure
NO FURTHER INCIDENT INFORMATION WAS RECEIVED, HOWEVER REVIEW OF RECEIVED IMAGES IS COMPLETED. PLEASE SEE H6 AND H11.
Patient problems: Obstruction/Occlusion; Thrombosis/Thrombus
MAUDE report 23287227 ↗InjuryJan 6, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
AS REPORTED THROUGH THE FRED X PAS CLINICAL STUDY, THE SUBJECT REPORTED TO THE EMERGENCY DEPARTMENT WITH COMPLAINT OF WORSENING LEFT UPPER EXTREMITY WEAKNESS AND NUMBNESS. IMAGING WAS PERFORMED THAT WAS NEGATIVE FOR STROKE AND POSITIVE FOR MICROEMBOLIC SIGNAL (MES). MES WAS INCIDENTAL FINDING AND TOO SMALL TO CAUSE THE INDICATED SYMPTOMS. THE SUBJECT WAS RE-STARTED ON DAPT. THE SUBJECT WAS DISCHARGED THE NEXT DAY. THE EVENT WAS ASSESSED AS POSSIBLY RELATED TO THE FLOW DIVERTER STENT DEVICE, WHICH WAS ORIGINALLY IMPLANTED ON (B)(6) 2023. THE ADVERSE EVENT IS ONGOING AND NO FURTHER UPDATES AVAILABLE AT THIS TIME.
Patient problems: Muscle Weakness/Atrophy; Numbness
MAUDE report 21087886 ↗
Other Intracranial aneurysm flow diverter devices
- Pipeline TM Flex Embolization Device with Shield Technology TM PED2-300-12Micro Therapeutics, Inc. · Intracranial aneurysm flow diverter2 recalls1 report
- PIPELINE PED-500-20Micro Therapeutics, Inc. · Intracranial aneurysm flow diverter1 recall31 reports
- PIPELINE PED-500-35Micro Therapeutics, Inc. · Intracranial aneurysm flow diverter1 recall1 death29 reports
- PIPELINE PED-500-16Micro Therapeutics, Inc. · Intracranial aneurysm flow diverter1 recall2 deaths27 reports
- PIPELINE PED-500-25Micro Therapeutics, Inc. · Intracranial aneurysm flow diverter1 recall1 death23 reports
- PIPELINE PED-500-30Micro Therapeutics, Inc. · Intracranial aneurysm flow diverter1 recall21 reports
- PIPELINE PED-450-25Micro Therapeutics, Inc. · Intracranial aneurysm flow diverter1 recall20 reports
- PIPELINE PED-475-30Micro Therapeutics, Inc. · Intracranial aneurysm flow diverter1 recall1 death19 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page